AVIR: the cash flow

MyFinsight

For the quarter ending 2026-03-31, AVIR had -$16,396K decrease in cash & cash equivalents over the period.

Cash Flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total research and development expense	39,210	45,490	92,088	-
Total general and administrative	5,069	4,859	17,730	-
Stock based compensation	3,729	4,585	16,135	-
Other segment items	-2,568	-10,067	-12,471	-
Net loss	-45,440	-44,867	-42,049	-71,433
Stock-based compensation expense	3,729	4,585	4,517	11,618
Depreciation and amortization expense	104	104	104	208
Accretion of premium and discounts on marketable securities	581	808	1,075	3,061
Income tax benefit	-	-6,356	-	-
Prepaid expenses and other current assets	-1,970	2,332	938	-1,743
Other assets	-88	-2,339	1,081	4,197
Accounts payable	-3,499	9,430	-5,329	4,386
Accrued expenses and other liabilities	-2,709	9,729	5,524	-2,602
Operating lease liabilities	-53	-47	-48	-95
Net cash used in operating activities	-46,391	-28,223	-40,375	-63,433
Purchases of marketable securities	74,546	43,791	14,780	223,368
Sales and maturities of marketable securities	104,284	90,383	56,083	324,266
Net cash provided by investing activities	29,738	46,592	41,303	100,898
Proceeds from issuance of common stock upon exercise of stock options	871	0	58	-
Stock repurchase	-	0	11,426	14,093
Proceeds from issuance of common stock under employee stock purchase plan	132	0	63	138
Issuance of restricted stock units	746	0	0	485
Net cash provided by (used in) financing activities	257	0	-11,305	-14,440
Net (decrease) increase in cash and cash equivalents	-16,396	18,369	-10,377	23,025
Cash and cash equivalents at the beginning of period	95,713	77,344	64,696	-
Cash and cash equivalents at the end of period	79,317	95,713	77,344	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.